Everbliss Everolimus 10mg Tablet

Everbliss Everolimus 10mg Tablet

15000 INR

Product Details:

  • Drug Type General Medicines
  • Ingredients Everolimus 10mg
  • Physical Form Tablets
  • Function Anti-Cancer
  • Recommended For breast cancer, pancreatic cancer, lung cancer and kidney cancer
  • Dosage AS PER DOCTOR ADVICE
  • Dosage Guidelines AS PER DOCTOR ADVICE
  • Supply Ability : 5000 Box BOXES Per Month
  • Click to view more
X

Price And Quantity

  • 15000 INR
  • 1 Box

Product Specifications

  • breast cancer, pancreatic cancer, lung cancer and kidney cancer
  • 1 Boxes
  • AS PER DOCTOR ADVICE
  • Tablets
  • AS PER DOCTOR ADVICE
  • Everolimus 10mg
  • Anti-Cancer
  • General Medicines
  • NORMAL TEMPRATURE
  • Aged Person, Adults

Trade Information

  • DELHI MUMBAI AHMEDABAD
  • Telegraphic Transfer (T/T), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 5000 Box BOXES Per Month
  • 10 DAYS Days
  • 10 TABLETS BOX PACK
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

Everbliss 10 mg Tablet is used in breast cancer, pancreatic cancer, lung cancer and kidney cancer. This tablet is also recommended to avoid organ rejection for patients of  organ transplantation. Advanced formulation of this drug boosts immunity power of human body so that it can accept newly transplanted organ. Offered drug is basically kinase inhibitor. It is composed of elements like butylated hydroxytoluene, anhydrous lactose, magnesium stearate etc. This medicine need to be taken at the same time on daily basis. Patient can take Everbliss Everolimus 10mg Tablet with or without food. Special care needs to be taken in case the patient is breastfeeding or pregnant woman. This medicine is suitable for adults and aged patients. Long storage life and side effects free content are some of its key factors.

SURETY HEALTHCARE

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.